[CNSP] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[CNSP] CNS Pharmaceuticals, Inc.
Announcement Date
14-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 18.47%
YoY- -12.76%
Quarter Report
CNSP's Result
CNSP's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,531 -4,021 -3,566 -3,814 -2,474 -432 -257 46.35%
Tax -0 8 0 0 0 7 6 -
NP -2,531 -4,021 -3,566 -3,814 -2,474 -432 -257 46.35%
Tax Rate - - - - - - - -
Total Cost 2,531 4,021 3,566 3,814 2,474 432 257 46.35%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -6.72 -51.86 -2.67 -4.50 -4.51 -0.98 -0.49 54.65%
EPS Diluted -6.72 -51.86 -2.67 -4.50 -4.51 -0.98 -0.49 54.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.